Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 11, 2015, Pages

  Bradford, Natalie K ^a   Edwards, Rachel M ^b   Chan, Raymond J ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; SODIUM CHLORIDE; FIBRINOLYTIC AGENT;

CATHETER INFECTION; CATHETER OCCLUSION; CHILD; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; HUMAN; INFANT; LONG TERM CARE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; CENTRAL VENOUS CATHETER; META ANALYSIS; PRESCHOOL CHILD;

CATHETER OBSTRUCTION; CENTRAL VENOUS CATHETERS; CHILD; CHILD, PRESCHOOL; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INFANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SODIUM CHLORIDE;

EID: 84964694219     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010996.pub2     Document Type: Review

References (51)

1. Cesaro S, Tridello G, Cavaliere M, Magagna L, Gavin P, Cusinato R, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology 2009;27(12):2059-65.
2. Goosens GA, Jerome M, Janssens C, Peetermans WE, Fieuws S, Moons P, et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology 2013;24(7):1892-9.
3. Goossens GA, Jerome M, Janssens C, Peetermans WE, Fieuws S, Moons P, et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer 2013;21:S28.
4. Smith S, Dawson S, Hennessey R, Andrew M. Maintenance of the patency of indwelling central venous catheters: is heparin necessary?. American Journal of Pediatric Hematology/Oncology 1991;13(2):141-3.
5. De Neef M, Heijboer H, Van Woensel JB, De Haan RJ. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatric Hematology and Oncology 2002;19(8):553-60.
6. Geritz MA. Saline versus heparin in intermittent infuser patency maintenance. Western Journal of Nursing Research 1992;14(2):131-7.
7. Kaneko Y, Iwano M, Yoshida H, Kosuge M, Ito S, Narita I, et al. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis. Blood Purification 2004;22(5):473-9.
8. Pumarola C, Casademont Mercader R, Colomer Plana M, Cordon Bueno C, Sabench Casellas S, Felez Vidal M, et al. Comparative study of maintenance of patency of triple lumen central venous catheter [Estudio comparativo del mantenimiento de la permeabilidad de los cateteres venosos centrales de tres luces]. Enfermeria Intensiva 2007;18(1):25-35.
9. Rabe C, Gramann T, Sons X, Berna M, Gonzalez-Carmona MA, Klehr HU, et al. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Medicine 2002;28(8):1172-6.
10. Schultz AA, Drew D, Hewitt H. Comparison of normal saline and heparinized saline for patency of IV locks in neonates. Applied Nursing Research 2002;15(1):28-34.
11. Abate ME, Escobosa-Sanchez O, Boschi R, Raspanti C, Loro L, Affinito D, et al. Analysis of risk factors for central venous catheters related complications: A prospective observational study in pediatric patients with bone sarcomas. Cancer Nursing 2013;37(4):292-8.
12. Athale UH, Siciliano S, Cheng J, Thabane L, Chan AK. Central venous line dysfunction is an independent predictor of poor survival in children with cancer. Journal of Pediatric Hematology/Oncology 2012;34(3):188-93.
13. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490-4.
14. Barclay CA, Vonderhaar KJ, Clark EA. The development of evidence-based care recommendations to improve the safe use of anticoagulants in children. The Journal of Pediatric Pharmacology and Therapeutics 2012;17(2):155-8.
15. Baskin JL, Pui C-H, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. The Lancet 2009;374(9684):159-69.
16. Bertoglio S, Solari N, Meszaros P, Vassallo F, Bonvento M, Pastorino S, et al. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nursing 2012;35(4):E35-42.
17. Bowers L, Gabel Speroni K, Jones L, Atherton M. Comparison of occlusion rates by flushing solutions for peripherally inserted central venous catheters with positive pressure Luer-activated devices. Journal of Infusion Nursing 2008;31(1):22-7.
18. Conway MA, McCollom C, Bannon C. Central venous catheter flushing recommendations: a systematic evidenced-based practice review. Journal of Pediatric Oncology Nursing 2014;31(4):185-90.
19. Davis MBH. Pediatric central venous catheter management: a review of current practice. Journal of the Association for Vascular Access 2013;18(2):93-8.
20. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
21. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
22. Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Annals of Oncology 2005;16(4):648-54.
23. Gonzalez G, Davidoff AM, Howard SC, Pui CH, Rao BN, Shenep JL, et al. Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children. Pediatric Blood & Cancer 2012;58(4):498-502.
24. McMaster University (developed by Evidence Prime, Inc) . GRADEpro Guideline Development Tool. Available from www.gradepro.org, 2015.
25. Education Department McMasters Children's Hospital. Protocol for CVC maintenance [personal communication]. Email to: HHS-education@HHSC.CA 29-May-2014.
26. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
27. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Versions 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
28. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
29. Jacobs BR, Schilling S, Doellman D, Hutchinson N, Rickey M, Nelson S. Central venous catheter occlusion: a prospective controlled trial examining the impact of a positive pressure valve device. Journal of Parenteral and Enteral Nutrition 2004;28(2):113-8.
30. Jarvis WR, Murphy C, Hall KK, Fogle PJ, Karchmer TB, Harrington G, et al. Health care-associated bloodstream infections associated with negative-or positive-pressure or displacement mechanical valve needleless connectors. Clinical Infectious Diseases 2009;49(12):1821-7.
31. Kelly L. The care of vascular access devices in community care. British Journal of Community Nursing 2008;13(5):198-205.
32. Lee OK, Johnston L. A systematic review for effective management of central venous catheters and catheter sites in acute care paediatric patients. Worldviews on Evidence-Based Nursing 2005;2(1):4-13, discussion 14-5.
33. Lopez-Briz E, Ruiz Garcia V, Cabello JB, Bort-Marti S, Carbonell Sanchis R, Burls A. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD008462.pub2]
34. Marschall J, Mermel LA, Classen D, Arias KM, Podgorny K, Anderson D, et al. Strategies to prevent central-line associated infections in acute care hospitals. Strategies 2008;29(S1):S22-S30.
35. Mitchell MD, Anderson BJ, Williams K, Umscheid CA. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. Journals of Advanced Nursing 2009;65(10):2007-21.
36. Moher D, Liberati A, Tezlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009;151(4):264-9.
37. Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Reviews 2010;24(2):63-8.
38. Nelson S, Armes S, Austin A, Clark N, Hicks G, Johnston J, et al. Care and maintenance to reduce vascular access complications. Registered Nurse's Association of Ontario International Affairs and Best Practice Guidelines Programs Guidelines Supplement 2008:1-7.
39. Revel-Vilk S, Yacobovich J, Tamary H, Goldstein G, Nemet S, Weintraub M, et al. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer 2010;116(17):4197-205.
40. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
41. Schallom ME, Prentice D, Sona C, Micek S, Skrupky L. Heparin or 9% sodium chloride to maintain central venous catheter patency: a randomized trial. Critical Care Medicine 2012;40(6):1820-6.
42. Schilling S, Doellman D, Hutchinson N, Jacobs BR. The impact of needleless connector device design on central venous catheter occlusion in children: a prospective, controlled trial. Journal of Parenteral and Enteral Nutrition 2006;30(2):85-90.
43. Schuster M, Nave H, Piepenbrock S, Pabst R, Panning B. The carina as a landmark in central venous catheter placement. British Journal of Anaesthesia 2000;85(2):192-4.
44. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
45. Shah PS, Kalyn A, Satodia P, Dunn MS, Parvez B, Daneman A, et al. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study. Pediatrics 2007;119(1):e284-e91.
46. Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infection and Immunity 2005;73(8):4596-606.
47. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
48. Stocco JGD, Crozeta K, Taminato M, Reichembach-Danski MT, Meier MJ. Evaluation of the mortality of neonates and children related to the use of central venous catheters: a systematic review. Acta Paulista de Enfermagem 2012;25(1):90-5.
49. Wong T, Clifford V, McCallum Z, Shalley H, Peterkin M, Paxton G, et al. Central venous catheter thrombosis associated with 70% ethanol locks in pediatric intestinal failure patients on home parenteral nutrition. A case series. Journal of Parenteral and Enteral Nutrition 2012;36(3):358-60.
50. Young G. New anticoagulants in children. ASH Education Program Book 2008;1:245-50.
51. Bradford NK, Edwards RM, Chan RJ. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD010996]